These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 15102919)

  • 1. Transient blockade of the CD11d/CD18 integrin reduces secondary damage after spinal cord injury, improving sensory, autonomic, and motor function.
    Gris D; Marsh DR; Oatway MA; Chen Y; Hamilton EF; Dekaban GA; Weaver LC
    J Neurosci; 2004 Apr; 24(16):4043-51. PubMed ID: 15102919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing and duration of anti-alpha4beta1 integrin treatment after spinal cord injury: effect on therapeutic efficacy.
    Fleming JC; Bao F; Chen Y; Hamilton EF; Gonzalez-Lara LE; Foster PJ; Weaver LC
    J Neurosurg Spine; 2009 Nov; 11(5):575-87. PubMed ID: 19929361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylprednisolone causes minimal improvement after spinal cord injury in rats, contrasting with benefits of an anti-integrin treatment.
    Weaver LC; Gris D; Saville LR; Oatway MA; Chen Y; Marsh DR; Hamilton EF; Dekaban GA
    J Neurotrauma; 2005 Dec; 22(12):1375-87. PubMed ID: 16379576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CD11d integrin antibody treatment restores normal serotonergic projections to the dorsal, intermediate, and ventral horns of the injured spinal cord.
    Oatway MA; Chen Y; Bruce JC; Dekaban GA; Weaver LC
    J Neurosci; 2005 Jan; 25(3):637-47. PubMed ID: 15659600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of effects of methylprednisolone and anti-CD11d antibody treatments on autonomic dysreflexia after spinal cord injury.
    Gris D; Marsh DR; Dekaban GA; Weaver LC
    Exp Neurol; 2005 Aug; 194(2):541-9. PubMed ID: 15890340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha4beta1 integrin blockade after spinal cord injury decreases damage and improves neurological function.
    Fleming JC; Bao F; Chen Y; Hamilton EF; Relton JK; Weaver LC
    Exp Neurol; 2008 Dec; 214(2):147-59. PubMed ID: 19038604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of the anti-CD11d treatment is reduced in rat models of spinal cord injury that produce significant levels of intraspinal hemorrhage.
    Geremia NM; Hryciw T; Bao F; Streijger F; Okon E; Lee JHT; Weaver LC; Dekaban GA; Kwon BK; Brown A
    Exp Neurol; 2017 Sep; 295():125-134. PubMed ID: 28587875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD11d Antibody Treatment Improves Recovery in Spinal Cord-Injured Mice.
    Geremia NM; Bao F; Rosenzweig TE; Hryciw T; Weaver L; Dekaban GA; Brown A
    J Neurotrauma; 2012 Feb; 29(3):539-50. PubMed ID: 22044160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD11d integrin blockade reduces the systemic inflammatory response syndrome after spinal cord injury.
    Bao F; Brown A; Dekaban GA; Omana V; Weaver LC
    Exp Neurol; 2011 Oct; 231(2):272-83. PubMed ID: 21784069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early anti-inflammatory treatment reduces lipid peroxidation and protein nitration after spinal cord injury in rats.
    Bao F; Chen Y; Dekaban GA; Weaver LC
    J Neurochem; 2004 Mar; 88(6):1335-44. PubMed ID: 15009633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A therapeutic time window for anti-CD 11d monoclonal antibody treatment yielding reduced secondary tissue damage and enhanced behavioral recovery following severe spinal cord injury.
    Ditor DS; Bao F; Chen Y; Dekaban GA; Weaver LC
    J Neurosurg Spine; 2006 Oct; 5(4):343-52. PubMed ID: 17048772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CD11d antibody treatment reduces free radical formation and cell death in the injured spinal cord of rats.
    Bao F; Dekaban GA; Weaver LC
    J Neurochem; 2005 Sep; 94(5):1361-73. PubMed ID: 15992367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autonomic dysreflexia after spinal cord injury: central mechanisms and strategies for prevention.
    Weaver LC; Marsh DR; Gris D; Brown A; Dekaban GA
    Prog Brain Res; 2006; 152():245-63. PubMed ID: 16198705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CD11d monoclonal antibody treatment for rat spinal cord compression injury.
    Hurtado A; Marcillo A; Frydel B; Bunge MB; Bramlett HM; Dietrich WD
    Exp Neurol; 2012 Feb; 233(2):606-11. PubMed ID: 21145887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autonomic dysreflexia and primary afferent sprouting after clip-compression injury of the rat spinal cord.
    Weaver LC; Verghese P; Bruce JC; Fehlings MG; Krenz NR; Marsh DR
    J Neurotrauma; 2001 Oct; 18(10):1107-19. PubMed ID: 11686496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An anti-CD11d integrin antibody reduces cyclooxygenase-2 expression and protein and DNA oxidation after spinal cord injury in rats.
    Bao F; Chen Y; Dekaban GA; Weaver LC
    J Neurochem; 2004 Sep; 90(5):1194-204. PubMed ID: 15312174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integrin inhibiting molecule decreases oxidative damage and improves neurological function after spinal cord injury.
    Bao F; Chen Y; Schneider KA; Weaver LC
    Exp Neurol; 2008 Dec; 214(2):160-7. PubMed ID: 18926823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minocycline Reduces the Severity of Autonomic Dysreflexia after Experimental Spinal Cord Injury.
    Squair JW; Ruiz I; Phillips AA; Zheng MMZ; Sarafis ZK; Sachdeva R; Gopaul R; Liu J; Tetzlaff W; West CR; Krassioukov AV
    J Neurotrauma; 2018 Dec; 35(24):2861-2871. PubMed ID: 30113266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of polyethylene glycol and magnesium sulfate administration on clinically relevant neurological outcomes after spinal cord injury in the rat.
    Ditor DS; John SM; Roy J; Marx JC; Kittmer C; Weaver LC
    J Neurosci Res; 2007 May; 85(7):1458-67. PubMed ID: 17410603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A monoclonal antibody to CD11d reduces the inflammatory infiltrate into the injured spinal cord: a potential neuroprotective treatment.
    Saville LR; Pospisil CH; Mawhinney LA; Bao F; Simedrea FC; Peters AA; O'Connell PJ; Weaver LC; Dekaban GA
    J Neuroimmunol; 2004 Nov; 156(1-2):42-57. PubMed ID: 15465595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.